Michal Kriegelstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michal Kriegelstein has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aleš Marek
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czechia
5 shared publications - David Profous
Department of Organic Chemistry, Palacký University Olomouc, 77900 Olomouc, Czech Republic
5 shared publications - Petr Cankař
Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 77900 Olomouc, Czech Republic
5 shared publications - Adam Přibylka
Department of Organic Chemistry Faculty of Science Palacký University Olomouc Czech Republic
4 shared publications - Milos Hroch
Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
3 shared publications Antonín Lyčka
2 shared publications
Latest Publications
- Open Access
- 9 July 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (28) , 9867-9884
Application of 19F NMR Spectroscopy for Determining the Absolute Configuration of α-Chiral Amines and Secondary Alcohols Using Trifluoromethylbenzoimidazolylbenzoic Acid
Axially chiral 2-(2-(trifluoromethyl)-1H-benzo[d]imidazol-1-yl)benzoic acid (TBBA) was employed as a chiral derivatizing agent for determining the absolute α-configuration of primary amines and secondary alcohols via 19F NMR spectroscopy. The method utilizes the trifluoromethyl group as a sensor, detecting the shielding effects induced by individual alcohol or amine substituents. This approach was tested on 46 alcohols and amines, demonstrating greater efficiency compared to the standard MTPA method.
- 9 July 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (28) , 9867-9884
Open AccessApplication of 19F NMR Spectroscopy for Determining the Absolute Configuration of α-Chiral Amines and Secondary Alcohols Using Trifluoromethylbenzoimidazolylbenzoic Acid
Axially chiral 2-(2-(trifluoromethyl)-1H-benzo[d]imidazol-1-yl)benzoic acid (TBBA) was employed as a chiral derivatizing agent for determining the absolute α-configuration of primary amines and secondary alcohols via 19F NMR spectroscopy. The method utilizes the trifluoromethyl group as a sensor, detecting the shielding effects induced by individual alcohol or amine substituents. This approach was tested on 46 alcohols and amines, demonstrating greater efficiency compared to the standard MTPA method.
- Open Access
- 1 July 2025
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 68 (9-10)
Synthesis of [3H]muscimol
Muscimol, a potent GABAA receptor agonist and psychoactive alkaloid found in Amanita mushrooms, is widely used as a tool compound in neurochemical research. Despite its importance, synthetic access to [3H]muscimol of high specific activity has remained limited due to the challenges associated with conventional labeling strategies. Herein, we report a novel synthetic approach for the preparation of [3H]muscimol based on the reduction of a suitably protected amide precursor using in situ generated tritioborane (BT3·THF). The precursor was synthesized in four steps from dimethyl acetylenedicarboxylate, and subsequent electrophilic reduction afforded [3H]benzyl‐protected muscimol in a radiochemical yield of 44 mCi (1.63 GBq) and a molar activity of 48.3 Ci/mmol (1.79 TBq/mmol). Final deprotection with HBr in acetic acid yielded [3H]muscimol·HBr in > 95% radiochemical purity. The method avoids the use of bulk tritiated water employed in established synthetic protocols and enables safe, reliable, and efficient access to this valuable radioligand for applications in GABA receptor studies.
- 1 July 2025
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 68 (9-10)
Open AccessSynthesis of [3H]muscimol
Muscimol, a potent GABAA receptor agonist and psychoactive alkaloid found in Amanita mushrooms, is widely used as a tool compound in neurochemical research. Despite its importance, synthetic access to [3H]muscimol of high specific activity has remained limited due to the challenges associated with conventional labeling strategies. Herein, we report a novel synthetic approach for the preparation of [3H]muscimol based on the reduction of a suitably protected amide precursor using in situ generated tritioborane (BT3·THF). The precursor was synthesized in four steps from dimethyl acetylenedicarboxylate, and subsequent electrophilic reduction afforded [3H]benzyl‐protected muscimol in a radiochemical yield of 44 mCi (1.63 GBq) and a molar activity of 48.3 Ci/mmol (1.79 TBq/mmol). Final deprotection with HBr in acetic acid yielded [3H]muscimol·HBr in > 95% radiochemical purity. The method avoids the use of bulk tritiated water employed in established synthetic protocols and enables safe, reliable, and efficient access to this valuable radioligand for applications in GABA receptor studies.
- Open Access
- 18 January 2025
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (7)
Late-stage labeling of diverse peptides and proteins with iodine-125
- 18 January 2025
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (7)
Open AccessLate-stage labeling of diverse peptides and proteins with iodine-125
- 27 September 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (20) , 15384-15385
Correction to “Axially Chiral Trifluoromethylbenzimidazolylbenzoic Acid: A Chiral Derivatizing Agent for α-Chiral Primary Amines and Secondary Alcohols To Determine the Absolute Configuration”
- 27 September 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (20) , 15384-15385
Correction to “Axially Chiral Trifluoromethylbenzimidazolylbenzoic Acid: A Chiral Derivatizing Agent for α-Chiral Primary Amines and Secondary Alcohols To Determine the Absolute Configuration”
- Open Access
- 14 July 2024
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 67 (9) , 314-323
Direct Multi‐Deuterium Labelling of Pirtobrutinib
Herein, we demonstrate an efficient method for multi‐deuterium labelling of pirtobrutinib—a Bruton's tyrosine kinase inhibitor recently approved by the FDA—using a straightforward hydrogen isotope exchange (HIE) reaction. A remarkably high level of deuterium incorporation was achieved using an excess of a Kerr‐type iridium catalyst. The key factor in the significant deuterium labelling was the decision to employ a deuterium uniformly labelled solvent, chlorobenzene‐d5, at an elevated temperature. Virtually, no d0–d3 species were detected, with only traces of d4–d5 isotopomers (< 5%) observable in the mass spectrum of pirtobrutinib‐d8, fulfilling requirements for stable isotope‐labelled internal standard. The labelled compound—mainly consisting of isotopomers d6–d9 at 82.4% of the total abundance—was isolated in a high yield (73%) and purity (99%). Noteworthy, fluorine group acting as a directing group was observed for the first time. Significant incorporation of deuterium in ortho‐positions, exceeding 87%, was observed. Interestingly, chlorinated solvent used in the HIE reactions was non‐specifically deuterated yielding up to 0.42 deuterium per chlorobenzene molecule even at an exceptionally low iridium catalyst loading of 4.17 × 10–2 mol%.
- 14 July 2024
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 67 (9) , 314-323
Open AccessDirect Multi‐Deuterium Labelling of Pirtobrutinib
Herein, we demonstrate an efficient method for multi‐deuterium labelling of pirtobrutinib—a Bruton's tyrosine kinase inhibitor recently approved by the FDA—using a straightforward hydrogen isotope exchange (HIE) reaction. A remarkably high level of deuterium incorporation was achieved using an excess of a Kerr‐type iridium catalyst. The key factor in the significant deuterium labelling was the decision to employ a deuterium uniformly labelled solvent, chlorobenzene‐d5, at an elevated temperature. Virtually, no d0–d3 species were detected, with only traces of d4–d5 isotopomers (< 5%) observable in the mass spectrum of pirtobrutinib‐d8, fulfilling requirements for stable isotope‐labelled internal standard. The labelled compound—mainly consisting of isotopomers d6–d9 at 82.4% of the total abundance—was isolated in a high yield (73%) and purity (99%). Noteworthy, fluorine group acting as a directing group was observed for the first time. Significant incorporation of deuterium in ortho‐positions, exceeding 87%, was observed. Interestingly, chlorinated solvent used in the HIE reactions was non‐specifically deuterated yielding up to 0.42 deuterium per chlorobenzene molecule even at an exceptionally low iridium catalyst loading of 4.17 × 10–2 mol%.
- Open Access
- 14 January 2024
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 67 (3) , 91-103
Synthesis of [3H]Org24598 using in‐house prepared [3H]MeI
The synthesis of tritium‐labelled glycine transporter 1 inhibitor Org24598 is reported. Because of the instability of the Org24598 skeleton under hydrogenation conditions, a synthetic approach using an in‐house prepared tritium‐labelled alkylating agent ([3H]MeI, SA = 26.2 Ci/mmol) was employed. Alternative methods of labelling are discussed.
- 14 January 2024
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 67 (3) , 91-103
Open AccessSynthesis of [3H]Org24598 using in‐house prepared [3H]MeI
The synthesis of tritium‐labelled glycine transporter 1 inhibitor Org24598 is reported. Because of the instability of the Org24598 skeleton under hydrogenation conditions, a synthetic approach using an in‐house prepared tritium‐labelled alkylating agent ([3H]MeI, SA = 26.2 Ci/mmol) was employed. Alternative methods of labelling are discussed.
- Open Access
- 4 April 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (15) , 12734-12746
Limitations of Trifluoromethylbenzoimidazolylbenzoic Acid as a Chiral Derivatizing Agent to Assign Absolute Configuration for β-Chiral Aminoalcohols
Axially chiral 2-(2-(trifluoromethyl)-1H-benzo[d]imidazole-1-yl)benzoic acid (TBBA) was used as a chiral derivatizing agent to evaluate the limits of absolute configuration assignment for β-chiral aminoalcohols. Seven Boc-aminoalcohols and eight variously N-substituted (S)-phenylglycinols were prepared, and their TBBA esters were analyzed by NMR spectroscopy. Diverse substitution at the β-position was employed to demonstrate the effect of structure on the general conformational model and reliability of the absolute configuration assignment. It was concluded that hydrogen bond formation and steric hindrance were the main factors affecting the correct assignment for Boc-aminoalcohols.
- 4 April 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (15) , 12734-12746
Open AccessLimitations of Trifluoromethylbenzoimidazolylbenzoic Acid as a Chiral Derivatizing Agent to Assign Absolute Configuration for β-Chiral Aminoalcohols
Axially chiral 2-(2-(trifluoromethyl)-1H-benzo[d]imidazole-1-yl)benzoic acid (TBBA) was used as a chiral derivatizing agent to evaluate the limits of absolute configuration assignment for β-chiral aminoalcohols. Seven Boc-aminoalcohols and eight variously N-substituted (S)-phenylglycinols were prepared, and their TBBA esters were analyzed by NMR spectroscopy. Diverse substitution at the β-position was employed to demonstrate the effect of structure on the general conformational model and reliability of the absolute configuration assignment. It was concluded that hydrogen bond formation and steric hindrance were the main factors affecting the correct assignment for Boc-aminoalcohols.
- 1 November 2021
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 64 (13) , 500-512
Synthesis of [13C6]-ibrutinib
Convenient and straightforward synthesis of ibrutinib labeled by carbon-13 isotope is reported. Isotopically labeled building block is introduced in the last step of reaction sequence affording sufficient isolated yield (7%) of [C-13(6)]-ibrutinib calculated towards starting commercially available [C-13(6)]-bromobenzene.
- 1 November 2021
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 64 (13) , 500-512
Synthesis of [13C6]-ibrutinib
Convenient and straightforward synthesis of ibrutinib labeled by carbon-13 isotope is reported. Isotopically labeled building block is introduced in the last step of reaction sequence affording sufficient isolated yield (7%) of [C-13(6)]-ibrutinib calculated towards starting commercially available [C-13(6)]-bromobenzene.
- 3 September 2020
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 85 (20) , 12912-12921
The Assignment of the Absolute Configuration of β-Chiral Primary Alcohols with Axially Chiral Trifluoromethylbenzimidazolylbenzoic Acid
Axially chiral trifluoromethylbenzymidazolylbenzoic acid (TBBA) was used as a chiral derivatization agent for the assignment of the absolute configuration of β-chiral primary alcohols. The structures varied from simple, aliphatic alcohols to complex, cyclic systems and highly substituted sugar derivatives. The NMR-based method was successfully implemented to evaluate 17 compounds and displayed ΔδPM values higher than 0.1 ppm in most cases, which makes TBBA superior to MTPA and MPA and comparable to 9-AMA.
- 3 September 2020
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 85 (20) , 12912-12921
The Assignment of the Absolute Configuration of β-Chiral Primary Alcohols with Axially Chiral Trifluoromethylbenzimidazolylbenzoic Acid
Axially chiral trifluoromethylbenzymidazolylbenzoic acid (TBBA) was used as a chiral derivatization agent for the assignment of the absolute configuration of β-chiral primary alcohols. The structures varied from simple, aliphatic alcohols to complex, cyclic systems and highly substituted sugar derivatives. The NMR-based method was successfully implemented to evaluate 17 compounds and displayed ΔδPM values higher than 0.1 ppm in most cases, which makes TBBA superior to MTPA and MPA and comparable to 9-AMA.